1-8 of 8
Carlos Montalban, MD
Close
Sort by
Journal Articles

Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy

Carlos Montalban, MD PhD, Antonio Diaz-Lopez, Alejandro Martín, MD PhD, Monica Baile, MD, Jose M. Sanchez, Juan-Manuel Sancho, MD PhD, Olga García, Silvana Novelli, Ana Monter Rovira, Antonio Salar, MD PhD, Mariana Bastos, MD, Antonio Gutierrez, MD PhD, Raul Cordoba, MDPhD, Teresa Arquero, Sonia González de Villambrosia, Gilberto Barranco, Raquel de Oña, Azueg Hong, Maria Casanova, Armando Lopez-Guillermo, Maria J. Rodriguez-Salazar, Juan F. Dominguez, Ruben Fernandez, Jose Antonio Queizan, Jose Rodriguez, Victor Abraira, Juan F. Garcia
Journal: Blood
Blood (2017) 130 (Supplement 1): 1559.
https://doi.org/10.1182/blood.V130.Suppl_1.1559.1559
Published: 2017
Journal Articles

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Miriam López-Parra, MD, Monica Bellei, MSc, PhD, Alessandro Rambaldi, MD Prof, Silvana Novelli, Carlos Panizo, MD PhD, Maurizio Martelli, Ivan Dlouhy, Mariana Bastos, MD, Antonio Gutierrez, MD PhD, Juan Manuel Sancho, MD PhD, María José Ramírez Sánchez, José M Moraleda, MD, Estrella Carrillo-Cruz, MD, Ana Isabel Jiménez Ubieto, Isidro Jarque, Umberto Vitolo, MD, Natalia de las Heras, Reyes Arranz, Javier Lopez Jimenez, Carlos Montalban, MD PhD, Maria Pascual, Paolo Corradini, MD, Sabela Bobillo, MD, Estefania García-Torres, Michele Spina, Giuseppe Rossi, MD, Martina Manni, PhD, Dolores Caballero, MD PhD, Massimo Federico, MD, Alejandro Martín, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2008.
https://doi.org/10.1182/blood.V130.Suppl_1.2008.2008
Published: 2017
Journal Articles

Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era

Antonio Gutierrez, MD PhD, Leyre Bento, Carlos Montalban, MD PhD, Antonio Diaz-Lopez, Heidys Garrote, Julian Freue, Lourdes Lopez, Raquel Oña, Ana Maria Martin Moreno, Armando Lopez-Guillermo, Ivan Dlouhy, Jordina Rovira, Mario Rodriguez, Jose M. Sanchez, Monica Baile, MD, Alejandro Martín, MD PhD, Silvana Novelli, Juan Manuel Sancho, MD PhD, Olga García, Antonio Salar, MD PhD, Mariana Bastos, MD, Maria J. Rodriguez-Salazar, Ruben Fernandez, Juan F. Dominguez, Jose Antonio Queizan, Sonia González de Villambrosia, Raul Cordoba, MDPhD, Victor Abraira, Juan F. Garcia, Jose Rodriguez
Journal: Blood
Blood (2017) 130 (Supplement 1): 827.
https://doi.org/10.1182/blood.V130.Suppl_1.827.827
Published: 2017
Journal Articles

Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy

Ana Batlle López, MD, PhD, Sonia Glez de Villambrosia, MD, Santiago Montes-Moreno, MD, Francisco Mazorra, MD, Andrés Insunza, MD, Anabel Sáez, MD, Carlos Montalban, MD, PhD, Lydia Sánchez, Juan F. Garcia, MD, Eva González-Barca, MD, A López, MD, MC Ruiz-Marcellan, MD, Manuela Mollejo, MD, Carlos Grande, MD, Cherie H. Dunphy, MD, ED His, MD, Ronald S. Go, MD, Carlo Visco, MD, Zijun Y. Xu-Monette, PhD, Ken H. Young, MD, Miguel Piris, MD, Eulogio Conde, Sr., MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2664.
https://doi.org/10.1182/blood.V118.21.2664.2664
Published: 2011
Journal Articles

Final Results of a Multicenter Phase II Trial with Translational Elements to Investigate the Possible Infective Causes of Ocular Adnexal Marginal Zone B-Cell Lymphoma (OAMZL) with Particular Reference to Chlamydia Species and the Efficacy of Doxycycline As First-Line Lymphoma Treatment (the IELSG#27 TRIAL)

Silvia Govi, MD, Riccardo Dolcetti, MD, Maurilio Ponzoni, MD, Elisa Pasini, RF, Silvia Mappa, MD, Marta Bruno Ventre, MD, Claudio Doglioni, MD, Francesco Bertoni, MD, Francesco Zaja, MD, Carlos Montalban, MD, PhD, Caterina Stelitano, MD, Maria Elena Cabrera, MD, Franco Cavalli, MD, Emanuele Zucca, MD, Andrés J.M. Ferreri, MD
Journal: Blood
Blood (2011) 118 (21): 267.
https://doi.org/10.1182/blood.V118.21.267.267
Published: 2011
Journal Articles

Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia,

J Valentin Garcia-Gutierrez, MD, PhD, Pilar Herrera, MD, PhD, Lorena L Abalo, Maria Dolores Rey, Maria Calbacho, Lourdes Ramos, Paloma Ramos, Carlos Montalban, MD, PhD, Javier Lopez-Jimenez, MD
Journal: Blood
Blood (2011) 118 (21): 3780.
https://doi.org/10.1182/blood.V118.21.3780.3780
Published: 2011
Journal Articles

Stratification Approach for Splenic Marginal Zone Lymphoma Based on Hemoglobin, Platelet Count, High LDH and Extrahilar Lymphadenopathy: The HPLL/ABC System

Carlos Montalban, MD, PhD, Victor Abraira, PhD, Luca Arcaini, Eva Domingo-Domenech, MD, Pablo Guisado-Vasco, MD, PhD, Emilio Iannitto, MD, Manuela Mollejo, MD, Estella Matutes, Andrés JM Ferreri, MD, Antonio Salar, MD, PhD, Andrea Carpaneto, MD, Ricardo Pérez, MD, Jose Luis Bello, Miguel Hernandez, Dolores Caballero, MD, Miguel A. Piris, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1583.
https://doi.org/10.1182/blood.V118.21.1583.1583
Published: 2011
Journal Articles

Follicular Lymphoma: Design of a Protein-Based Survival Predictor Using Tissue-Microarrays (TMA).

Francisca I. Camacho, MD, Reyes Arranz-Saez, MD, Alessia Caleo, MD, Jimena Cannata, MD, Laura Cereceda, Leocricia Gonzalez, MD, Mª Elena Perez-Martin, MD, Lydia Sanchez-Verde, PhD, Carlos Montalban, MD, Juan F. Garcia, MD, Miguel A. Piris, MD, Carmen Bellas, PhD
Journal: Blood
Blood (2004) 104 (11): 2266.
https://doi.org/10.1182/blood.V104.11.2266.2266
Published: 2004